About this trial
Researchers aim to evaluate impact of transcutaneous electric nerve stimulator on the incidence of postoperative diaphragmatic dysfunction in patients living with obesity undergoing bariatric surgery
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Body mass index > 40 kg/m2
ASA II
Disqualifiers
Limited diaphragmatic ultrasound views
Patient with pulmonary diseases (COPD, bronchial asthma, and interstitial fibrosis)
Patient refusal
Trial design
Parallel
Treatments tested in this trial
Transcutaneous nerve stimulator
DeviceThe EM49 will be set to a TENS program with a frequency of 80-100 Hz and a pulse width of 200 μs
Sham TENS
DeviceElectrodes will be placed identically, but no current will be delivered (sham TENS)
Treatment groups
Trial outcomes
Primary outcomes
Incidence of postoperative diaphragmatic dysfunction
Diaphragmatic excursion \< 10 mm 2 hours after surgery
Secondary outcomes
Forced vital capacity (liters)
is the maximum volume of air that can forcibly exhaled after taking maximum breath
Numeric rating scale
To quantify pain from 0 to 10 (with 10 indicates worst pain)
Nalbuphine consumption
Total postoperative nalbuphine consumption
Forced expiratory volume in one second (Liter)
Maximum volume of air can be exhaled in the first second after maximum inspiration
Sponsors and contacts
Click on the lead sponsor to view all of their trials.